Currency: CNY
Period
Q1 FY2024 Earnings
--
2.73B
0.21
Strong Buy
May 11, 2024
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Annual Report
Apr 30 00:00
Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the first quarter of 2024
Summary of the 2023 Annual Report of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Annual Results Pre-loss Announcement
Jan 31 00:00
Read more
Updated: May 11, 2024
Buy
Hold
Underperform
Sell
No Data